TC Biopharm Announced It Has Advanced Negotiations With Both Of Its Previously Aforementioned Acquisition Candidates. The Company Will Be Focusing Its Acquisition Efforts On Two Main Areas; Natural Kill Cell Technologies And CAR-Related Technologies
Author: Benzinga Newsdesk | December 31, 2024 10:16am